COVID-19 Update: Chloroquine / Hydroxychloroquine and Azithromycin

Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug’s potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.

Hippocratic Post
Share:  

More in this category

Leave a Reply

Please Login to comment
  Subscribe  
Notify of